Skip to Main Content

2,921

Views

9

CrossRef citations to date

0

Altmetric

Research Article

Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule

Xitlally Popaa Clinical Research Direction, Center of Molecular Immunology, Havana, CubaView further author information

,

Beatriz Garcíaa Clinical Research Direction, Center of Molecular Immunology, Havana, CubaView further author information

,

Karla P. Fuentesa Clinical Research Direction, Center of Molecular Immunology, Havana, CubaView further author information

,

Vivian Huertab Systems Biology, Center for Genetic Engineering and Biotechnology, Havana, CubaView further author information

,

Karen Alvarezb Systems Biology, Center for Genetic Engineering and Biotechnology, Havana, CubaView further author information

,

Carmen E. Viadaa Clinical Research Direction, Center of Molecular Immunology, Havana, CubaView further author information

,

Elia Neningerc Oncology Department, Hermanos Ameijeiras University Hospital, Havana, CubaView further author information

,

Pedro C. Rodrígueza Clinical Research Direction, Center of Molecular Immunology, Havana, CubaView further author information

,

Zuyen Gonzáleza Clinical Research Direction, Center of Molecular Immunology, Havana, CubaView further author information

,

Amnely Gonzáleza Clinical Research Direction, Center of Molecular Immunology, Havana, CubaView further author information

,

Tania Crombeta Clinical Research Direction, Center of Molecular Immunology, Havana, CubaView further author information

&

Zaima Mazorraa Clinical Research Direction, Center of Molecular Immunology, Havana, CubaCorrespondence[email protected]
View further author information